| Not Yet Recruiting | Digital Physiotherapy for Pediatric Chronic Suppurative Lung Diseases NCT07376187 | University of Thessaly | N/A |
| Recruiting | A Clinical Study of RSS0343 in Healthy Subjects NCT07289464 | Reistone Biopharma Company Limited | Phase 1 |
| Recruiting | A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE NCT07245407 | AstraZeneca | — |
| Recruiting | Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchie NCT07048262 | CSL Behring | Phase 2 |
| Not Yet Recruiting | A Multicenter, Randomized, Double-blind, Placebo-controlled Parallel-group Phase 2 Clinical Trial to Evaluate NCT06981091 | S-INFINITY Pharmaceuticals Co., Ltd | Phase 2 |
| Recruiting | Long-term Evaluation of the SIMEOX Device at Home in Non-cystic Fibrosis Bronchiectasis NCT06487273 | Physio-Assist | N/A |
| Recruiting | A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease NCT06603246 | Genentech, Inc. | Phase 1 / Phase 2 |
| Recruiting | Hypertonic Saline in NCFB NCT06242795 | University of North Carolina, Chapel Hill | Phase 4 |
| Active Not Recruiting | Nebulised RESP30X Nitric Oxide Formulations in NCFB Patients With Pseudomonas Aeruginosa (Pa) NCT06663176 | Thirty Respiratory Limited | Phase 1 / Phase 2 |
| Recruiting | A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis NCT06660992 | Haisco Pharmaceutical Group Co., Ltd. | Phase 3 |
| Recruiting | A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis NCT06559150 | Verona Pharma plc | Phase 2 |
| Not Yet Recruiting | Procalcitonin as a Marker of Severity of Non-cystic Fibrosis Bronchiectasis in Children NCT06352944 | Assiut University | — |
| Completed | Impact of Support Groups for Patients With Non-Cystic Fibrosis Bronchiectasis NCT06164470 | University of California, San Francisco | N/A |
| Unknown | Early Detection of Pulmonary Exacerbations in Non-cystic Fibrosis Bronchiectasis NCT06151366 | Papworth Hospital NHS Foundation Trust | — |
| Recruiting | Breathing Training and Exercise Capacity in Non-CFB NCT05860803 | Mayo Clinic | N/A |
| Completed | Simeox Therapy at Home Versus Standard of Care in NCFB Patients With CMH NCT06237348 | Physio-Assist | N/A |
| Completed | Trikafta for Patients With Non-cystic Fibrosis Bronchiectasis NCT05743946 | Emory University | Phase 4 |
| Completed | Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibr NCT05616221 | Armata Pharmaceuticals, Inc. | Phase 2 |
| Completed | Phase 2a, 28-day Investigational Use Study of ARINA-1 in Non-Cystic Fibrosis Bronchiectasis (NCFBE) With Exces NCT05495243 | Renovion, Inc. | Phase 2 |
| Completed | A Study to Evaluate the Effect of Probiotic Supplement on Quality of Life NCT05523180 | ResBiotic Nutrition, Inc. | N/A |
| Terminated | Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis NCT05006573 | AstraZeneca | Phase 3 |
| Terminated | A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are NCT04656275 | Boehringer Ingelheim | Phase 1 |
| Completed | A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibros NCT04594369 | Insmed Incorporated | Phase 3 |
| Completed | Roflumilast in Non-CF Bronchiectasis Study (2019) NCT04322929 | The University of Hong Kong | Phase 2 |
| Completed | A Clinical Study to Investigate Safety, Tolerability and Distribution of CHF 6333 After One or After Repeated NCT04010799 | Chiesi Farmaceutici S.p.A. | Phase 1 |
| Unknown | Inhalations of Ultra-low Doses of Melphalan for the Treatment of Non-cystic Fibrosis Bronchiectasis NCT04278040 | Federal State Budgetary Institution, Pulmonology Scientific Research Institute | Phase 2 |
| Completed | Roflumilast in Non-CF Bronchiectasis Study NCT03428334 | The University of Hong Kong | Phase 2 |
| Completed | Exercise Capacity in Non-cystic Fibrosis Bronchiectasis After a Pulmonary Rehabilitation Home-based Program NCT05369624 | Hospital Universitario Virgen Macarena | N/A |
| Terminated | Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate NCT03460704 | Zambon SpA | Phase 3 |
| Completed | Assessment of INS1007 in Participants With Non-Cystic Fibrosis Bronchiectasis NCT03218917 | Insmed Incorporated | Phase 2 |
| Completed | Nutritional Status and Intake in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB) NCT06877091 | University of Leeds | — |
| Completed | Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I) NCT03093974 | Zambon SpA | Phase 3 |
| Completed | Dose-finding Study to Assess the Efficacy, Safety and Tolerability of Tobramycin Inhalation Powder in Patients NCT02712983 | Novartis Pharmaceuticals | Phase 2 |
| Completed | A Study to Investigate Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of CHF6333 in Heal NCT03056326 | Chiesi Farmaceutici S.p.A. | Phase 1 |
| Unknown | The Role of Pulmonary Rehabilitation and Airways Clearance Techniques in the Multidisciplinary Management of N NCT02614300 | Hospital Clinic of Barcelona | N/A |
| Completed | The Effects of Pulmonary Rehabilitation in Patients With Non-cystic Fibrosis Bronchiectasis NCT02883101 | All India Institute of Medical Sciences | N/A |
| Completed | Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-4) NCT02104245 | Aradigm Corporation | Phase 3 |
| Completed | Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis NCT02088216 | Qilu Hospital of Shandong University | N/A |
| Completed | Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3) NCT01515007 | Aradigm Corporation | Phase 3 |
| Completed | Combined Administration of Nebulized Amikacin in Patients With Acute Exacerbation of Non-Cystic Fibrosis Bronc NCT02081963 | Qilu Hospital of Shandong University | Phase 4 |
| Completed | Safety and Efficacy Study of Ciprofloxacin for Inhalation in Patients With Non-Cystic Fibrosis Bronchiectasis NCT00889967 | Aradigm Corporation | Phase 2 |
| Completed | The Sputum Colour Chart as a Predictor of Lung Inflammation and Proteolysis in Non-cystic Fibrosis Bronchiecta NCT01792440 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Mortality in Non-cystic Fibrosis Bronchiectasis NCT01792427 | Universitaire Ziekenhuizen KU Leuven | — |
| Approved For Marketing | An Expanded Access Study to Assess Brensocatib for Participants With Non-Cystic Fibrosis Bronchiectasis NCT05344508 | Insmed Incorporated | — |